Secondary metabolites from Pseudallescheria boydii and their anti-melanoma activity

被引:0
|
作者
Qin, Su-Lu [1 ]
Ding, Jia-Xin [1 ]
Huang, Cheng-Yun [1 ]
Li, Jing [1 ]
Yao, Ming [1 ]
Liu, Qing-Pei [1 ]
Wang, Wen-Jing [1 ]
Yang, Xiao-Long [1 ]
机构
[1] South Cent Minzu Univ, Sch Pharmaceut Sci, Wuhan 430074, Peoples R China
基金
中国国家自然科学基金;
关键词
Pseudallescheria boydii; beta-carboline alkaloids; Asperitaconic acid; Cyclotetrapeptide; Anti -melanoma activity; Network pharmacology; METASTATIC MELANOMA; CONSTITUENTS; AGENTS;
D O I
10.1016/j.tet.2023.133663
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A new asperitaconic acid (1) and an undescribe cyclotetrapeptide (2), together with nine known compounds (3-11), were isolated from the endophytic fungus Pseudallescheria boydii XL-0256 obtained from the leaves of Dimocarpus longan Lour. The structures of the new compounds have been successfully assigned based on the NMR spectroscopic data and the mass spectrometric analysis. Compound 3 was confirmed to significantly reduce B16-F10 cell viability in a dose- and time-dependent manner, as well as promoting cell apoptosis and inhibiting cell migration in B16-F10 cell. In addition, compound 3 was hypothesized to have an anti-melanoma effect through target proteins (ADAM17 and ADAMTS5) based on network pharmacological target prediction and molecular docking studies.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Vertebral osteomyelitis secondary to Pseudallescheria boydii
    Lonser, RR
    Brodke, DS
    Dailey, AT
    JOURNAL OF SPINAL DISORDERS, 2001, 14 (04): : 361 - 364
  • [2] Secondary metabolites with chemical diversity from the marine-derived fungus Pseudallescheria boydii F19-1 and their cytotoxic activity
    Lan, Wen-Jian
    Wang, Kun-Teng
    Xu, Meng-Yang
    Zhang, Jing-Jing
    Lam, Chi-Keung
    Zhong, Guo-Hua
    Xu, Jun
    Yang, De-Po
    Li, Hou-Jin
    Wang, Lai-You
    RSC ADVANCES, 2016, 6 (80) : 76206 - 76213
  • [3] Anti-Melanoma Activity of Stellettin A
    Liu, W. K.
    Cheung, F. W. K.
    Ling, Y. H.
    Che, C. T.
    PLANTA MEDICA, 2013, 79 (10) : 830 - 830
  • [4] Activity of posaconazole against Pseudallescheria boydii:: In vitro and in vivo assays
    González, GM
    Tijerina, R
    Najvar, LK
    Bocanegra, R
    Rinaldi, MG
    Loebenberg, D
    Graybill, JR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (04) : 1436 - 1438
  • [5] Synthesis and Anti-Melanoma Activity of Acryloyl Pyridinone Analogues
    Urbaniak, Alicja
    Bathula, Chandramohan
    Chauhan, Jyoti
    Rai, Prateek
    Thammathong, Joshua
    Clark, Christopher
    Heflin, Billie
    De Loose, Annick
    Avaritt, Nathan
    Rodriguez, Analiz
    Tackett, Alan J.
    Sen, Subhabrata
    Banerjee, Souvik
    CHEMISTRY & BIODIVERSITY, 2023, 20 (12)
  • [6] In vitro anti-melanoma activity of imiquimod in ultradeformable nanovesicles
    Tatiana Caimi, Ayelen
    Ramirez, Cecilia
    Paula Perez, Ana
    Lilia Romero, Eder
    Jose Morilla, Maria
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2022, 48 (11) : 657 - 666
  • [7] FUNGAL PANOPHTHALMITIS SECONDARY TO SCEDOSPORIUM-APIOSPERMUM (PSEUDALLESCHERIA-BOYDII) KERATITIS
    KSIAZEK, SM
    MORRIS, DA
    MANDELBAUM, S
    ROSENBAUM, PS
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 118 (04) : 531 - 533
  • [8] Polyketides from the Littoral Plant Associated Fungus Pseudallescheria boydii
    Chang, Ya-Chih
    Deng, Tzu-Shing
    Pang, Ka-Lai
    Hsiao, Che-Jen
    Chen, Yi-Ying
    Tang, Shye-Jye
    Lee, Tzong-Huei
    JOURNAL OF NATURAL PRODUCTS, 2013, 76 (09): : 1796 - 1800
  • [9] Osteoclastogenesis Regulation Metabolites from the Coral-Associated Fungus Pseudallescheria boydii TW-1024-3
    Liu, Da-Hua
    Sun, Yi-Zhe
    Kurtan, Tibor
    Mandi, Attila
    Tang, Hua
    Li, Jiao
    Su, Li
    Zhuang, Chun-Lin
    Liu, Zhi-Yong
    Zhang, Wen
    JOURNAL OF NATURAL PRODUCTS, 2019, 82 (05): : 1274 - 1282
  • [10] Orbital apex syndrome secondary to Pseudallescheria boydii fungal sinusitis in an immunocompetent patient
    Thiagalingam, S
    Fernando, GT
    Tan, K
    O'Donnell, BA
    Weeks, K
    Branley, M
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2004, 32 (05): : 545 - 547